在子中,阿尔多斯激素对 ангиотензин压力阻断
Science (New York, N.Y.)
|August 23, 1963
概括
阿尔多前期治疗减少了子对抗压剂血管素的反应. 这一发现可能解释了为什么有时高血压不存在,尽管血管新生素和阿尔多斯特水平升高.
科学领域:
- 心血管生理学心血管生理学
- 内分泌学 在内分泌学.
- 脏系统 脏系统
背景情况:
- 高血压是一种由荷尔蒙调节影响的复杂疾病.
- ангиотензин 和 阿尔多是控制血压的关键激素.
- 血管素和阿尔多激素在预防高血压方面的相互作用需要进一步阐明.
研究的目的:
- 为了研究阿尔多素预处理对子对血管素的压力反应的影响.
- 为了探索潜在的机制背后的缺乏高血压在条件下高血管素和阿尔多素.
主要方法:
- 子被预先用阿尔多斯特治疗.
- 测量了对血管素的压力反应.
- 对血液动力学参数进行了监测.
主要成果:
- 阿尔多前期治疗显著降低了对血管素的压力反应.
- 这表明阿尔多素在血管素诱导的血管收缩中起着调节作用.
结论:
- 阿尔多可能在抗血管素诱导的高血压方面起着保护作用.
- 这些发现为在特定的临床场景中提供了对高血压病理生理学的见解.
相关概念视频
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...